Dr Thomas Chan is currently working as consultant haematologist at the Queen Mary Hospital (QMH) of Hong Kong. He graduated from the University of Hong Kong with honours and obtrained his fellowship in Haematology and Haematological Oncology in 2013. His special interests include lymphoid malignancies and cellular immunotherapies, including CAR-T cell therapy. He is currently the clinical lead of the CAR-T cell service at QMH.
Early bird registration is open and closes May 2025. Register now
